Tevogen Bio Holdings Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 9,363 | 6,086 | 8,599 | 29,517 | 2,009 |
| Operating Income | -9,363 | -6,086 | -8,599 | -29,517 | -2,009 |
| Interest Expense | 16 | 13 | 0 | 156 | 318 |
| Other Income | -66 | 214 | -1,064 | 40,937 | -1,305 |
| Pre-tax Income | -9,445 | -5,884 | -9,663 | 11,265 | -3,632 |
| Net Income Continuous | -9,445 | -5,884 | -9,663 | 11,265 | -3,632 |
| Net Income | $-9,445 | $-5,884 | $-9,663 | $11,265 | $-3,632 |
| EPS Basic Total Ops | -4.00 | -1.50 | -2.00 | 4.00 | -98.50 |
| EPS Basic Continuous Ops | -3.92 | -1.73 | -3.13 | 4.10 | -98.48 |
| EPS Diluted Total Ops | 13.00 | -1.50 | -2.00 | -13.00 | -98.50 |
| EPS Diluted Continuous Ops | -3.77 | -1.73 | -3.13 | 3.96 | -98.48 |
| EPS Diluted Before Non-Recurring Items | -3.00 | -1.50 | -2.00 | N/A | N/A |
| EBITDA(a) | $-9,260 | $-5,984 | $-8,499 | $-29,418 | $-1,908 |